首页> 外国专利> RWL-1 Pharmaceutical composition for preventing or treating gastrointestinal disorder comprising as an active ingredient a compound isolated from Bacillus amyloliquefaciens RWL-1 culture medium

RWL-1 Pharmaceutical composition for preventing or treating gastrointestinal disorder comprising as an active ingredient a compound isolated from Bacillus amyloliquefaciens RWL-1 culture medium

机译:RWL-1预防或治疗胃肠道疾病的药物组合物,其包含从解淀粉芽孢杆菌RWL-1培养基中分离的化合物作为活性成分。

摘要

The present invention relates to a composition for preventing, solving, and treating gastrointestinal diseases comprising a compound isolated from a culture medium of Bacillus amyloliquefaciens RWL-1 strain and is the first to describe the enzyme inhibitory activity of a bioactive compound isolated from Bacillus amyloliquefaciens species. Since the compound of the present invention has excellent urease inhibitory activity, the compound has an effect of inhibiting the urease activity of Helicobacter pylori and making Helicobacter pylori difficult to survive in the gastric mucosa. Therefore, the compound is effective for treating, preventing, and solving gastrointestinal diseases. The compound uses a secondary metabolite of microorganisms and is expected to be useful in the medical and food industries by using it as an important source of a bioactive metabolite with high therapeutic value.
机译:本发明涉及用于预防,解决和治疗胃肠道疾病的组合物,其包含从解淀粉芽孢杆菌RWL-1菌株的培养基中分离的化合物,并且是第一个描述从解淀粉芽孢杆菌种分离的生物活性化合物的酶抑制活性的化合物。 。由于本发明的化合物具有优异的脲酶抑制活性,因此该化合物具有抑制幽门螺杆菌的脲酶活性并使幽门螺杆菌难以在胃粘膜中存活的作用。因此,该化合物对于治疗,预防和解决胃肠道疾病是有效的。该化合物利用微生物的次生代谢产物,通过将其用作具有高治疗价值的生物活性代谢产物的重要来源,有望用于医疗和食品工业。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号